American Society of Gene and Cell Therapy Revenue and Competitors

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • American Society of Gene and Cell Therapy's estimated annual revenue is currently $7.5M per year.(i)
  • American Society of Gene and Cell Therapy's estimated revenue per employee is $91,463

Employee Data

  • American Society of Gene and Cell Therapy has 82 Employees.(i)
  • American Society of Gene and Cell Therapy grew their employee count by 5% last year.

American Society of Gene and Cell Therapy's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
President & FounderReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Director CommunicationsReveal Email/Phone
5
Director, Meetings & EventsReveal Email/Phone
6
Director TechnologyReveal Email/Phone
7
Medical Director Child, Adolescent and Family ServicesReveal Email/Phone
8
Director Science and EducationReveal Email/Phone
9
Managing Editor & Director Scientific PublicationsReveal Email/Phone
10
Senior Manager Development, Annual Meeting & ExhibitsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M524%N/AN/A
#2
$35M3445%N/AN/A
#3
N/A327%N/AN/A
#4
$7.5M11128%N/AN/A
#5
$15M1474%N/AN/A
#6
$3.5M320%N/AN/A
#7
N/A50%N/AN/A
#8
$35M53-4%N/AN/A
#9
$35M3310%N/AN/A
#10
$75M251N/AN/AN/A
Add Company

What Is American Society of Gene and Cell Therapy?

The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

keywords:N/A

N/A

Total Funding

82

Number of Employees

$7.5M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.6M82-5%N/A
#2
$35M82-7%N/A
#3
$11.9M825%N/A
#4
$27.4M839%N/A
#5
$18.9M830%N/A